Introduction
Saturation transfer is a well-known effect in magnetic resonance, exploited in analytical spectroscopic contexts for several decades. 1 These phenomena have become widely used also in biological settings with the advent of chemical exchange saturation transfer (CEST) and magnetization transfer (MT) measurements. Endogenous contrast mechanisms that arise when selectively irradiating peaks associate to either labile hydrogens or to other sites that can eventually lead to changes in the water signal intensity. [1] [2] [3] [4] [5] [6] [7] CEST in particular highlights molecules carrying labile hydrogens, including fundamental metabolites such as creatine, glucose, glutamate and urea. [8] [9] [10] [11] Chemical exchanges between these species and water can be determined by recording so-called Z-spectra, multi-scan experiments where the effect on the water peak is monitored upon applying presaturating radiofrequency (RF) pulses irradiating at an array of offsets. While this frequencyselective saturation procedure forfeits the possibility of interrogating all the labile hydrogens simultaneously, this is compensated by the potential amplification of the site specific information afforded by CEST. In the slow exchange regime, this amplification will be on the order of kex . T1 water -where kex is the rate of solvent exchange of the labile hydrogen and T1 water is the relaxation time of the solvent. 2, 6, 7 In favorable cases this magnification can reach ≈100-1000, leading to the possibility of using CEST as an in vivo metabolic imaging tool. The most prominent CEST peaks do not usually arise in either healthy or tumorous brain tissues from metabolites but rather from amide groups and aliphatic sidechains in proteins, or from other macromolecular components. [12] [13] [14] The reduction in the water signal intensity arising when saturating endogenous contrast sources positioned 3.5 ppm downfield from water is usually referred to as the amide proton transfer (APT) contribution to CEST MRI. Z-spectra also often reveal water saturation upon irradiating upfield of the water resonance, in a region where no labile protons resonate. This effect is usually assigned to the saturation of lipid end groups or of protein sidechains that, via direct cross-relaxation with structural water molecules or via cross-relaxation with protons in amides or in hydroxyls that then exchange with H2O, result in partial saturation of the bulk water peak. Regardless of the exact transfer pathway, these are known as nuclear Overhauser effect (NOE) contributions. 15, 16 Finally, besides these relatively narrow dips arising upon saturating specific species, changes in the water signal intensity may arise in vivo when irradiating over a much larger range of frequency offsets -as far as 10 ppm away from the water resonance. These changes originate from the saturation of protons in semi-solid macromolecules, whose dipolar-broadened lines can be subject to couplings in the tens of kHz. When irradiating this homogeneously broadened background, saturation can be transferred to the free water resonance via cross-relaxation or even by direct dipolar coupling with structural water molecules at a rate kMT; as these free up and become "normal", liquid-like water molecules, the dominating water signal intensity drops. This forms the basis of the magnetization transfer (MT) contrast, which is often considered as a phenomenon akin to -but distinct from-CEST. Besides all these information-carrying contributions there may also be contribution to the Zspectrum associated to changes that the water peak itself experiences when performing offresonance irradiation. These contributions to the water's peak saturation will incorporate a variety of relative relaxation (T1, T2, T2 * ) and RF (B1) factors. In order to deal with these "spillover effects", it is customary to compute both CEST-and MT-derived images by performing two experiments where saturation is symmetrically placed around the water resonance. It is then the relative difference between these two effects, known as the magnetization transfer ratio asymmetry MTRasym(), which is usually reported in these experiments. Further corrections may have to be introduced to account for shifts in the water resonance position within the targeted region-ofinterest (ROI). 17 To disentangle all these competing and simultaneous mechanisms that can contribute to the MTRasym an increasing number of sophisticated signal processing approaches have been proposed, including quantitative techniques based on single or multi-Lorentzian fitting models, and on Bloch equation calculations. 16, [18] [19] [20] [21] Z-spectra and images deriving from CEST and MT effects depend on physiologically valuable parameters including metabolic concentrations, temperature and pH. 12, 14, 22, 23 They also depend on parameters that are metabolically less meaningful but spectroscopically important, including the solvent's access to and exchange with the protons of macromolecules and metabolites, as well as the latter's species spin relaxation properties. A particularly important variable in defining the nature of CEST and MT parameters is the magnetic field strength B0. Besides the well-known enhancements in sensitivity and in resolution arising upon increasing B0, higher fields will separate the frequency differences  (in Hz) between the exchanging species and water. This will in turn expand the range of processes that can contribute to the CEST/MT observations, and whose rates kex, kMT need to be on the order of  (or smaller) in order to enable a substantial magnification of the targeted resonances. In complex systems such as living tissues, these k's will normally entail a heterogeneous distribution of frequencies; increasing  by moving to higher fields thus increases the range of participating processes, augmenting the experiment's contrast. 21 Furthermore, as field increases, water -which although a small molecule interacts strongly with its surrounding environment-will lengthen its T1 with Bo. 24, 25 The overall k . T1 water product defining MT/CEST's maximum amplification is thus expected to increase with the operating field B0. Such behavior has been observed in preliminary paramagnetic and diamagnetic CEST measurements 26, 27 and recently reported in a preclinical field-comparative study, 28 suggesting that the use of ultrahigh fields could open hitherto untapped contrasting possibilities. The present study explores this hypothesis, by applying CEST imaging methodologies to examine brain-related conditions on rats at 21.1 T. The two conditions chosen were glioma and stroke, diseases that have been extensively used to study injuries to brain's white and gray matters by CEST MRI in the past. [12] [13] [14] [15] [29] [30] [31] [32] [33] [34] [35] [36] [37] In those studies an MTRasym increase of approximately 2 to 10% was observed at ca. +3.5 ppm, upon comparing glioma with healthy brain tissue. 13, [29] [30] [31] [32] 35, 37, 38 Moreover, since chemical exchange rates of amides depend on the tissue micro-environment, 4, 14, 15 APT-derived CEST weighting has been proposed as an imaging method to quantify pH and from there to detect brain strokes. 12 In this study an intense MTRasym contrast was observed at 21.1 T on glioma rat tissues, considerably larger than that hitherto observed at lower fields. Several processing methods were used to identify and quantify the various contributions to this enhanced MTRasym. By contrast, the changes in MTRasym did not reach statistical significance in the stroke cases, providing much weaker reporters than T2 or diffusion observables when examined 24 hs post-stroke. Potential explanations for these features and prospects of additional ultrahigh magnetic field studies in these brain investigations, are discussed.
5/23

Experimental Methods
Animal handling: All surgical procedures were carried out under aseptic conditions in accordance with the guidelines for animal experimentation from the ethical committee of the Florida State University Animal Care and Use Committee. FSU is registered as a research facility with the United States Department of Agriculture (USDA Registration #58-R-0001) and has an Animal Welfare Assurance number (#A3854-01) on file with the US Public Health Service. All animal procedures were undertaken according to these regulatory bodies and AAALAC guidelines, under the direction of a veterinarian who is certified as a specialist in laboratory animal medicine by the American College of Laboratory Animal Medicine (ACLAM). Naïve Sprague Dawley rats were purchased from Envigo Corp. (Tampa, FL, USA) and delivered one week prior to surgery for acclimatization to the new environment. All animals were housed individually in a 12 hr night/12 hr daylight cycle with water and food available ad libitum. For each disease model, male Sprague-Dawley rats weighing between 200-250 gr were randomly chosen from the cohort of available animals. Seven animals were chosen to provide statistical significance results by means of power analysis, while at the same time minimize the number of animals used. After an aseptical preparation, the surgical site was infiltrated with 0.2 mL of 0.5% Bupivicaine (Hospira, Lake Forest, IL). In addition, 0.05 mg/kg of buprenorphine (Reckitt Benckiser Pharmaceuticals, Inc.) was injected subcutaneously and every 4-6 hour or as needed for pain management. After surgery, all animals were given pre-warmed fluids (3-5 mL 1X PBS) intraperitoneally to facilitate recovery. Animals were let to recover in a pre-warmed (37°C) recovery cage. Euthanasia was performed in guidance with the 2007 American Veterinary Medical Association (AVMA) Guidelines on Euthanasia. After the last MRI session animals were anesthetized with isoflurane and exposed to CO2 for a fast and pain free euthanasia. Once respiratory failure and cardiac arrest had occurred, a cervical dislocation was performed.
Ischemic animal model:
Seven juvenile male Sprague-Dawley rats were anesthetized with 5% isoflurane (Baxter, Deerfield, IL) in an induction chamber and maintained on 3-4% isoflurane during the surgical procedure. After administration of a local nerve block (Bupivicaine), the common carotid artery, external carotid artery and internal carotid artery were exposed by blunt and sharp dissection. A 3.0-cm filament with a 0.35-mm thick and 2-3 mm long rubber coating (Doccol Corp, Redlands, CA, USA) was inserted through the ECA. The filament was guided 1.9 cm into the ICA or until the middle carotid artery (MCA) was blocked. The transient occlusion occurred for 1.5 h, followed by re-anesthetization and removal of the filament. The animals were imaged 24 h following the occlusion; no mortalities were documented during the course of the experiments.
Glioma animal model: 9L glioma cells were cultured and expanded in 75 cm 3 tissue culture flasks with Dulbeccos modified Eagle's medium (DMEM) (Sigma Chemical Co. St Louis, MO) supplemented with 10% fetal bovine serum (Atlanta Biological, Alanta, GA, USA), 1% antibiotics/antimyotics (Gibco, Invitrogen Corp., Carlsbad, CA, USA) and 0.1% gentamycin (Invitrogen Corp., Carlsbad, CA, USA). Cells were kept at a temperature of 37 °C and under 5% CO2. Immediately before implantation surgery, cells were harvested with trypsin (Gibco, Invitrogen Corp., Carlsbad, CA, USA), pelleted by centrifugation, and re-suspended in phosphate buffered saline (PBS). For intra-cranial implantation, eleven Sprague-Dawley rats were used. Animals anesthetized with isoflurane were secured in a stereotaxic frame with continuous flow of 2-3% Isoflurane. A 1-cm mid-line incision was made over the skull and the dermal tissues were kept separated by bull clamps. Using the bregma as reference, a 1-mm burr hole was made 2 mm anterior and 2.5 mm lateral. Using a sterile Hamilton syringe (SigmaAldrich, St Louis, MO), 100,000 9L glioma rat cells in 10 µL of sterile PBS were injected at depth of 3.5 mm from the skull. Immediately after the removal of the syringe, bone wax was used to seal the burr hole and 70% ethanol applied to the skull to prevent any cells from forming exogenous tumors. The incision was then sealed with sutures. Animals were imaged 7 and 11 days following implantation. Two rats died between days 7 and 11.
CEST MRI acquisitions:
All data were acquired using the 105-mm bore, 21.1 T (900 MHz) vertical magnet available at the National High Magnetic Field Laboratory MRI/MRS user facility in Tallahassee, FL, USA. 39 The magnet is equipped with a Bruker Avance III console running on Paravision ® 5.1 (Bruker Biospin, Billerica, MA), and imaging gradients (Resonance Research Inc., Billerca, MA) delivering a peak strength of 600 mT/m with rise times of 120 µs. A custom-built transmit/receive quadrature double saddle surface coil was used in these 1 H MR experiments, whose performance -including B1 specifications-has been recently described. 40 The coil is part of a probe equipped with a bite-bar supplying continuous flow of anesthesia and provisions to maintain animals at a constant temperature. Prior to their in vivo imaging all animals were anesthetized with 5% Isoflurane; this was then lowered to 2% and adjusted to maintain a respiratory rate between 30-40 breaths/min as monitored with a pneumatic pillow situated under the animal (SA Instruments Inc., Stony Brook, NY). Scout fast low angle shot images (FLASH, TE/TR=4/50 ms) were collected to help with the animal positioning; this was followed by CEST-weighted 1 H rapid acquisition with relaxation enhancement (RARE) spin-echo (SE) images, collected with echo and recycling times of TE/TR=9/5000 ms. As CEST-based MRI is an intrinsically time consuming experiment, its ability to generate neurological contrast for the aforementioned models was studied at 21.1 T in two experimental stages. One of this involved a low resolution, fast protocol; the second was a lengthier protocol with high spatial and spectral resolution plus inhomogeneity corrections, aimed at better defining the possibilities of CEST at this field.
Fast, low-resolution CEST MRI: Five MCAO animals and six glioma-bearing animals were scanned using a fast, low-resolution CEST MRI protocol. These images were acquired from a 32x32-mm 2 field of view, using a 1-mm slice thickness and a 250x250 µm 2 in-plane resolution. The CEST preparation module consisted of a train of 400 10-ms Gaussian pulses with a B1 field of 3.5 µT, each of them followed by a low intensity spoiler gradient. To obtain full Z-spectra, the frequency offset of the saturating pulse train was varied between -10 and +10 ppm relative to water, with a 1-ppm increment step between ±10 and ±4 ppm and a 0.5-ppm step between -4 and +4 ppm (23 increments in total). The total scan time for this CEST MRI protocol was ca. 30 minutes.
High resolution CEST MRI: Two MCAO and five glioma-bearing animals were scanned using a high spectral resolution CEST MRI protocol. These images were acquired from a 32x32-mm 2 field of view, using a 1-mm slice thickness and a 200x200 µm 2 in-plane resolution. The CEST preparation module consisted of a train of 400 10-ms Gaussian pulses with a B1 field of 1.5 µT, with the frequency offset of these pulses varied between -5 and +5 ppm relative to water in 0.2-7/23 ppm steps (56 increments). CEST images were also recorded at ±100, ±20 and ±10 ppm in order to establish the wider Z-spectral contributions during quantification. Water saturation shift referencing (WASSR) maps 17 were also acquired for these experiments, and their impact on the CEST data when attempting to correct for water frequency shifts was assessed. These WASSR preparation modules consisted of a single 200-ms long saturation Gaussian pulse with a B1 of 0.5 µT, and frequency offsets varying from -0.3 to +0.3 ppm with a 0.05-ppm step (13 increments). In order to check the field homogeneity and the RF transmission performance, B0 and B1 maps were acquired using, respectively, a 3D phase imaging sequence (Fieldmap, 128x128 matrix) and a saturated double-angle method. 41 The total scan time for this CEST MRI protocol was ca. 3 hours.
Data processing: CEST/MT-weighted images were processed and quantified using a customized MATLAB ® (The Mathworks Inc, Nantucket, MA) code. This quantification involved computing MTRasym maps, generated as , where S(±) reflect the water signal intensity upon irradiating at two frequencies symmetrically placed with respect to the water, and S0 is a water reference signal acquired when the saturation frequency is far off-resonance (+100 ppm in this study). With MTRasym maps obtained in this manner the rat brain images were manually segmented, and two ROIs were selected highlighting either normal or diseased (ischemic or glioma) brain tissues. For each animal, the optimal saturation frequency  yielding the highest MTRasym contrast between normal and diseased tissues was estimated, and employed for later statistical use. WASSR maps were generated using a spline interpolation and MTRasym maps were calculated with and without B0 correction. A Lorentzian fit difference (LFD) processing 20 was also applied to each voxel in the analysis of their corresponding Z-spectra. The purpose of the LFD was to extract CEST components after suppressing the direct water saturation (spillover) effects, and the procedure was performed in two steps. First, an automatic fitting procedure adjusted the amplitude and damping parameters of a double-Lorentzian model centered on 0 ppm using a least-squares optimization method; subsequently, the residual of this double-Lorentzian fit was extracted to reveal any residual CEST components disturbing the symmetry of a pure water Z-spectrum. Upfield and downfield CEST contributions were also quantified using another method: the so-called threeoffset technique. 15, 34 Here the Z-spectrum is linearly interpolating between two a priori chosen frequency offsets of interest (for instance two offsets 1 ppm apart), and then a search is made for the maximum difference between this fitted line and the original spectrum, so as to reveal the offset and amplitude of any CEST component potentially present. APT/NOE contributions were quantified in these two fashions between frequency offsets of +2/+4 ppm and -2/-5 ppm respectively, and quantitative APT/NOE maps were thus generated. Other spectral contributions centered at +2 and 1.8 ppm were quantified using [+1.6;+2.4] and [-2;-1.5] ppm chemical shift ranges.
Statistical Analysis: Quantitative measures were averaged over the indicated ROIs and are presented with +/-standard deviation of the mean. Statistical significance was determined with students T-test with significance set at the p-values indicated in the text. Results Figure 1 shows representative T2-weighted, B1 and WASSR maps obtained on an MCAO animal at 21.1 T. The quadrature double saddle surface coil used in these experiments 40 is able to generate a relatively homogeneous B1 coverage of the rat brain, with only slight drops in power in the lower and peripheral parts. Similarly, B0 field homogeneity was excellent in the upper and central parts of the brain, as evidenced by the WASSR maps. In general, the largest frequency shifts were evidenced in the lower parts of the brain, likely originating distortions imposed by proximity to the nose and to the ear canals, compounded by low SNR due to the surface coil sensitivity profile and. Figures 2 and 3 illustrate axial RARE results acquired for different Z-spectral offsets, for a glioma-implanted rat at days 7 and 11 post-injection of the cancerous cells, and for two different saturation conditions. Notice for all cases the intensification and the expansion of the contrast in the right hemisphere, as the tumor develops. Interestingly, similar contrasts between normal brain and glioma-invaded tissues are observed under low and high B1 CEST conditions. Nevertheless, the low B1 experiments allowed the observation of spectrally selective CEST effects, by reducing the sensitivity to the broad MT effects otherwise observable up to 10 ppm. Figure 4 offers a description of this, with the MTRasym contrast displayed by glioma tissue when recorded (on a different animal) using the high-resolution CEST imaging protocol. Shown in panel (a) are anatomical T2-weighted images, which themselves show only a weak contrast stemming from the tumor. Figure 4b are the Z-spectral data observed as a function of frequency, when integrated over ROIs associated with healthy (green) and diseased (red) tissues. The large differential CEST changes are highlighted by the MTRasym spectrum, as this results from subtracting contributions on opposite sides of the water resonance (Fig. 4c ). The CEST MTRasym maps shown in Figure 4d illustrate how, upon choosing the most intense asymmetry offset, the tumor can be clearly distinguished from healthy tissue at both stages (similar maps are presented for additional MTRasym offsets in Figure 2 ). When considered over the n=5 animal cohort studied under the low-power conditions, the maximum MTRasym contrast for glioma tissue was statistically observed at 4.0±0.5 ppm for the day-7 time point, and at 3.7±0.1 ppm for the day-11 time point. For those offsets, the average changes in MTRasym between normal and glioma brain tissue were, respectively, 6.2±1.9 % and 7.3±1.5 %. Figure 5 shows an alternative way of processing these CEST data. These images show quantitative maps obtained for different irradiation frequencies, upon using the LFD method on data acquired from a rat bearing a 7-day glioma. As reminder, this Lorentzian deconvolution is done to remove the effects of direct water saturation as well as potentially also magnetization transfer effects (though the latter are relatively weak under the low B1 conditions pertaining these data); the residual highlights all remaining, physiologically relevant mechanisms acting as main sources of contrast. A weak contrast is then observed upon saturating at ca. -3.5 ppm, in the region normally associated with aliphatic resonances, and a positive contrast appears at +3.5 ppm, in the region normally associated with labile hydrogens and APT effects. Notice that this is opposite to the trend shown by the localized Z-spectra illustrated in Figure 4 , which revealed a strong decrease in 9/23 MTRasym contrast's absolute value for the cancerous tissues. Figure 5b gives a different rendering of these changes and illustrates, after averaging over normal and diseased brain ROIs for the full animal cohort studied at B1=1.5 µT, the Z-spectra arising for different chemical shifts after subtracting the water/MT spillover contributions. These LFD results highlight the APT increase associated to the glioma. The signal processing approach, in combination with the high-resolution Z-spectrum acquisition conditions, then shows to a number of finer Z-spectral features at these 21.1T field. These include downfield CEST contributions usually ascribed mostly to intrinsic protein constituents: amides at +3.5 ppm, side-chain amines at +2.5 ppm, 42 creatine plus other amines usually assigned to the +2 ppm peak (although this has also been tentatively connected by MAS NMR cross relaxation experiments to aromatic sidechains 43 ), and a novel feature arising at +4.6 ppm. The spectral LFD deconvolution of the upfield NOE hump also reveals a fine structure, including a -1.8 ppm NOE-mediated peak that has been associated to choline head groups, 44 and peaks at -3.0, -3.5 and -3.8 ppm that have been related to macromolecular methylene and methyl protons. 45 Figure 6 shows a further evaluation of these results for the n=5 animal cohort in the low-power glioma study, this time quantifying the CEST behavior based on the "three-offsets" technique reported by Gore and coworkers. 34 This approach also successfully identifies the eight peaks noted in Figure 5 ; out of all these Figure 6 focuses solely on the four peaks where potentially significant changes were seen upon focusing on ROIs containing healthy and glioma-bearing tissues. This quantification evidenced a positive change in intensity when considering the APT region between normal brain and day-11 glioma tissue (Fig. 6a, p<0.1 ). More significant NOE changes were evidenced by the upfield part of the spectrum (Fig. 6b) , with a -1.3% decrease (p<0.05) between normal brain and day-7 glioma tissue and a -1.4% decrease (p<0.05) in the case of day-11 glioma tissues. The amines component at +2 ppm and the minor NOE component at -1.8 ppm also showed significant changes (p<0.1), between normal brain and day-11 glioma tissue ( Fig. 6c and 6d ).
It is interesting to contrast these glioma data, which are mutually consistent regardless of the adopted data-processing approach, against 21.1 T results observed when the pathology is associated with a MCAO-derived ischemia. Figure 7 shows how this event, clearly seen in the anatomical images of the stroked animals when investigated 24 hs after the injury, fails to reveal a particular chemical shift for which a significant MTRasym is evidenced under the low-power, high-resolution CEST conditions used in the glioma studies. This is further illustrated by the Z-spectral images shown in Figure 8 , where the dominant direct water saturation was subtracted using the LFD method. Some contrast features are evident by these residuals, but these do not correspond to the stroked regions. This absence that does not mean that the Z spectra are identical for healthy and stroked regions: in general, we observe under these conditions a slight decrease of a spectrally broad effect on the latter (e.g., Fig. 7) . These could reflect different MT behaviors, but also differences in the water relaxation characteristics (and thereby in the spillover and the saturationtransfer effects) between healthy and diseased tissues. Moreover, unlike in the glioma case, the asymmetry of these saturation-transfer plots about the water is not significantly distorted upon going from one kind of tissue to the other. As illustrated in the Supporting Information, a similar behavior is observed when examining MCAO animals 24 hs post-occlusion, under high-power (B1 10/23 = 3.5µT) saturating conditions. This robs the 21.1T MTRasym plots from contrast capabilities: over the n=5 cohort that we analyzed using the low-resolution / high B1 CEST imaging protocol and the n=2 cohort analyzed at high-resolution / low B1, no significant change (p>0.5) in either APT or NOE regions could be quantified for the ischemic tissues.
Discussion and Conclusions
Multiple physical factors suggest that saturation-based contrasts in MRI should benefit from operating at the highest possible fields. The range of chemical exchange rates accessible in this manner would increase due to a larger chemical shift dispersion expanding in turn the NMR timescales, while water's lengthening in vivo T1s 24, 25, 46 mean that the imprint of the saturation onto the bulk water pool could also be increased. 19, 21, 42, 47 The relation between B0 strength and CEST, however, is not straightforward. As mentioned, larger CEST effects have been observed for glucose and other agents at 21.1 T than at lower fields; 26, 27 NOE and MT effects have also been reported to increase for human gliomas with increasing fields. 37 The present 21.1 T study is in agreement with this latter trend, as for both healthy and glioma tissues, enhancements are observable. Subtler, however, is the extraction of systematic conclusions about how these saturation processes depend on field. Thus, while remarkable MTRasym contrasts were observed at either high or low presaturation powers for the glioma, MTRasym effects were always ambiguous for ischemia -a lesion that at this field could be much more robustly detected at these fields with standard T2-weighted images or by diffusion measurements. 48 The strong contrast observed at 21.1 T when comparing tumor versus normal brain tissues, can be traced to an increase in the downfield chemical exchange effects and to a decrease in the upfield NOE and magnetization transfer effects. APT increases in brain tumors have been reported at lower fields in animals (4.7 and 9.4 T 13, 29, 34, 35 ) and in humans (3 and 7 T 30, 37, 38 ) , with the enhancements ranging between +1 and +4%. Interestingly, we were not able to compute a significant correlation between the APT contrasts reported in the literature and the employed B0 fields. This is not entirely unexpected since, apart from similar MTRasym values, the reported APT contrasts present in the literature are very heterogeneous and were obtained with different acquisition protocols and of APT quantification approaches -thus preventing quantitative comparative studies. Still, and in agreement with literature trends, a significant (p<0.1) +0.2% APT increase was observed when comparing normal brain to day-11 glioma tissues. The changes in the upfield saturation has been less clearly established for glioma tissue, and only at high preclinical (9.4 T) or clinical fields (7 T) have decreases in CEST effects ranging between -1 and -2%, been reported for this NOE componentdepending on the quantification tool. 31, 32, 34, 37, 38, 49 In agreement with these reports, a -1.3 to -1.4% decrease was observed in the extent of the upfield saturation peak at 21.1 T, which together with the increase in the APT CEST contributed to an MTRasym contrast amounting to ca. -6.2% when focusing at ca. +4.0 ppm under lower-power saturation conditions (Fig. 4c ). An even larger, ≥|5%| drop is observed in the upfield saturation when operating under high-power conditions, which together with the APT increase leads to an MTRasym contrast amounting to ≈-15% when focusing at ca. +3.3 ppm (Fig. 3 ). This is, to our knowledge, the largest contrast hitherto observed by CEST on gliomas. The sizable drop in MT under these conditions is observable at chemical shifts far away from water -as distant as -10 ppm. Recent works have suggested that glioma's rise in APT may be related to an increased protein content in tumors, 50 a claim that remains to be backed by biochemical measurements of total protein contents in normal and malignant brains. 34 Alternatively, the rise in APT could reflect a change in intracellular pH that increases the rate of proton exchange, or the onset of protein unfolding facilitating amide exchanges with water. 14, 51 As for the drop observed in the upfield NOE response, this could also be related to structural changes, including protein unfolding or progressive cellular membrane fracture. 16 In any case, out of all the effects, it is the drop in MT that yields the main source of contrast between healthy and glioma tissues -an effect that, although to very different extents, happens regardless of whether a low or high B1 saturation power is used (see Supplementary Information for examples of the latter). MT originates from "immobile" protons present in proteins, macromolecules or lipids, and exhibits a maximum effect ca. -2 ppm upfield from the H2O resonance. 7, 52 The MT drop observed in the strongB1, 21.1 T experiments is in agreement with recent results observed in 9L rat glioma tissue at 9.4 T, 34 even if the increased frequency separation and the longer water T1 in the field here used probably enhances this change. Whereas such broad and baseline CEST signals strongly compromise the asymmetry analysis when attempting to estimate APT and NOE contributions, the LFD and the three-offsets quantification methods are not sensitive to this effect and provide a solid high-field observable that can highlight the progress of the disease. The exact reasons behind this MT reduction remain to be defined, but it would be reasonable to link them to a degradation of the structural tissue integrity, to an onset of necrosis, and to an increase in water content as the glioma grows. 53 The presence and changes in the dominant MT contribution compromises the estimation of the finer APT and NOE contributions, particularly when attempting an MTRasym analysis at high B1 fields. The deconvolution that the LFD and the three-offsets quantification methods carry out, however, provide reliable observables that can disentangle CEST peaks under moderate B1 conditions. The use of a high Z-spectral resolution coupled with the spectral separation power arising at 21.1 T, reveal in this manner APT and NOE contributions at -3.8, -3.0, -1.8, +2.0, +2.6, +3.5 and +4.6 ppm away from the water peak. The two upfield components at -3.8 and -3.0 ppm are usually associated to protein and/or membrane methyl and methylenes, and they did not show significant variations between healthy and diseased tissues. Zhang et al 44 reported a NOE-mediated signal around -1.6 ppm in ischemic rats at 9.4 T, which we believe corresponds to the -1.8 ppm peak observed here. This peak was tentatively assigned to choline phospholipids; while Zhang et al saw a minor decrease in this peak in their stroke study, the 21.1 T Z-spectra revealed an increase in day-11 glioma compared to normal brain tissues for this peak (Fig. 6d) . By contrast, no statistically significant change was observed for this peak in the MCAO rats ( Figs. 7 and 8) . The labile amine sites of creatine and protein guanidino amine groups at ca +2 ppm 55, 56 show a slight but significant drop in the glioma cases ( Fig. 6c ), in agreement with the literature reporting a decrease in 9L tumors in rats. 54 A slight increase is observed in tumorous tissues for the +3.5ppm peak (Fig. 6c ), which could reflect the onset of protein unfolding and concurrent solvent exposure for the amide peaks. This is also as previously observed at lower fields. 54 Finally, a low intensity but significantly glioma-increased CEST signal was detected at +4.6 ppm relative to water. To our knowledge no reports of endogenous CEST agents for such chemical shifts are available; a potential source for this peak could be nicotinamide, which has chemical shifts ranging between 8.6 and 9.6 ppm. And while NAD + concentrations in brain are extremely low (≈500µmol/L), de Graaf et al were able to detect this metabolite in vivo using a non-water suppressed MRS sequence thanks to its substantial exchange with the solvent. 57 By contrast to these marked healthy-vs-tumor tissue effects, saturation-transfer imaging at 21.1 T provided poor contrast when applied to the ischemic rat model (Figs. 7 and 8) . Previous CEST imaging studies suggest a decrease in APT of +1 to +3% in ischemic brain tissue, 12, 14, 15, 36, 44 reflecting perhaps the acidic environment induced by the ischemia. On the other hand NOE is reported to remain nearly unchanged by ischemia. 44 The present study revealed differences between ischemic and normal Z spectra, but no statistically significant MTRasym of LFD peaks emerging at 21.1 T. Indeed, most of the visual differences arising in Figure 7 between normal and ischemic tissues, were erased in the images shown in Figure 8 after deconvolving the direct and MT saturation components. Interestingly, a slight narrowing of the Z-spectra acquired in ischemic tissues can be observed; this could originate from a number of factors including changes in the relaxation properties of water (as visible on the T2-weighted images) or from more complex mechanisms involving a pH-modulation of both APT and NOE effects. 58 All our measurements were done once, at 24h post MCAO; since ischemia is supposed to exhibit a fast temporal evolution, it remains to see whether these CEST measurements and their lack of contrast at 21.1T, would vary with time. 36 Regardless of this, these stroke measurements suggest that the more favorable chemical shift dispersion and longer water T1 characteristically provided by ultrahigh field operation, do not always translate into unambiguously stronger CEST peaks.
In summary, CEST methods were applied at 21.1 T to investigate the contrasts arising for two widely investigated neurological disorders. Both of these had been investigated previously in human and rodent models at lower fields; when repeated at ultrahigh fields at low and high B1 saturation fields, strong endogenous saturation-transfer contrasts resulted for MRI of gliomas. The origins of these could be traced to changes in the APT and NOE contributions to CEST, as well as on MT effects originating from the solid-like tissue matrices. Interestingly, the use of ultrahigh field in combination with relatively low powers and with high resolution Z-spectral conditions, successfully resolved in both healthy and glioma brain regions multiple CEST signals usually entangled at lower fields. New, potentially useful endogenous markers for glioma were also identified in this manner. By contrast, poor MTRasym changes could be observed for ischemic tissues under similar conditions, a limitation whose exact origin is still under examination. The ischemic tissue is clearly visible in the left hemisphere of the brain on the T2-weighted image. The B1 map shows a general homogeneity over the brain with a slight over-tipping effect near the coil (top of the brain) whereas the WASSR map reveals an overall high B0 homogeneity with ≈0.15 ppm heterogeneities in the lower brain regions.
Figure Captions
Figure 2:
MTRasym maps obtained on a glioma-implanted rat brain using the low power (B1=1.5 µT) high-resolution CEST imaging protocol, for two different days following cell implantation. Top: 7 days after the injection of 9L glioma cells. Bottom: 11 days after the cells injection. In addition to the dominant tumor-derived features a relatively strong positive MTRasym can be observed in the lower parts of the brain for some chemical shifts, likely due to low SNR and B0 inhomogeneities originating from the ear canals and the sinuses (cf. Fig. 1 ). Marked by the red contours are the approximate regions invaded by the glioma.
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Figure 3:
MTRasym maps obtained on a glioma-implanted rat brain using the low-resolution, highpower CEST imaging protocol, for two different days following cell implantation. Top: 7 days after the injection of 9L glioma cells. Bottom: 11 days after the cells injection. The RF saturation used here was stronger (3.5 µT) than that used in Figure 2 , and allowed the observation of evidences an intense glioma contrast from 2.5 to 10 ppm likely originating from MT effects (red encircled regions). Notice the strong positive contrast appearing at +3.5 ppm (APT) and the slight negative contrast observed at -3.5 ppm (NOE) for the tumorous tissue. (b) Average Z-spectra obtained using LFD over different tissues and at different stages, over the n=5 animal cohort hereby studied. The black arrows indicate multiple spectral features arising in these water-detected data at ca. -3.8 -3.5, -3.0, -1.8, +2.0, +2.6, +3.5 and +4.6 ppm, and the glioma-induced changes in these contributions as function of the days elapsed since injection. The vertical scale denotes % with resect to the maximum water signal S0.
Figure 6:
Average quantification of the CEST contrast changes obtained using the three-offset integration technique for (a) the +3.5 ppm amide peak, (b) the NOE peak at -4 ppm, (c) the +2 amine peak, and (d) the -1.8 ppm peak., Results reflect an n=5 animal cohort. Vertical axes scales are as in Fig. 5b . Statistical significance was determined based on a paired student t-test. The error bars represent the standard error of mean (SEM) obtained over the n animals included in the group study. : Quantitative CEST maps obtained for different saturation frequencies using the Lorentzian fit difference method on data acquired using the high-resolution CEST imaging protocol on a MCAO rat. No specific contrast could highlight the ischemic brain tissue, whose region is illustrated by the red ROI. LFD colormap scale is as in Fig. 5b. 
